Showing results (301-310 of 464) with videos related to
Sort By:
Pageof 47
Infection and Immunity|June 1, 1976
Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane componentsI Dörner, H Brunner, H G Schiefer, et al.Der Nervenarzt|January 5, 2005
[Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake]M Singer, B Romero, E Koenig, et al.Arzneimittel-Forschung|January 1, 1977
[New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)]H Brunner, S Djawan, W Dorda, et al.Artificial Organs|May 1, 1983
Electrodialysis and reverse osmosis as a regeneration system for hemofiltrateK Hintzen, S Stiller, H Brunner, et al.Infection and Immunity|December 1, 1991
Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cellsM H Wang, H D Flad, W Feist, et al.Biochemistry|June 3, 1999
NMR experiments reveal distinct antibody-bound conformations of a synthetic disaccharide representing a general structural element of bacterial lipopolysaccharide epitopesT Haselhorst, J F Espinosa, J Jiménez-Barbero, et al.FEMS Immunology and Medical Microbiology|January 1, 1994
The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine inductionT Kirikae, F U Schade, U Zähringer, et al.FEMS Immunology and Medical Microbiology|January 1, 1994
Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigenL Brade, H Brunnemann, M Ernst, et al.Carbohydrate Research|October 31, 1989
Determination of the epitope specificity of monoclonal antibodies against the inner core region of bacterial lipopolysaccharides by use of 3-deoxy-D-manno-octulosonate-containing synthetic antigensA Rozalski, L Brade, H M Kuhn, et al.Infection and Immunity|November 1, 1994
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structuresB Weidemann, H Brade, E T Rietschel, et al.Pageof 47